Menu
Recruiting NCT05907161

Low Laser Therapy and Hyaluronic Acid as an Adjunct to Non-surgical Periodontal Therapy

No phase Interventional Periodontitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: SRP+LASER (Dentsply Sirona - SIROLaser Blue), SRP+HA, SRP.
Who it may be relevant to
Registry conditions: Periodontitis. Basic parameters: 25 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Slovenia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Low Laser Therapy and Hyaluronic Acid as an Adjunct to Non-surgical Periodontal Therapy in Patients With Periodontitis

Overview

Periodontal disease is an oral disease characterized by microbially associated, host-mediated inflammation of the periodontium. In the treatment of periodontal disease, conventional periodontal therapy includes both surgical and non-surgical approaches. Non-surgical therapy (i.e. scaling and root planing - SRP) remains an essential part of periodontal therapy. Here, diseased root surface debridement utilizing different hand and ultrasonic instrumentation is performed to facilitate periodontal re-attachment and to reduce the bacterial mass in the periodontal pocket. In the last decade, the use of lasers (light amplification by stimulated emission of radiation) has occupied part of the dialogue within periodontology due to several proposed advantages. In the arena of periodontology, laser use, as an adjunct to non-surgical therapy, was demonstrated to enhance periodontal healing; however, it is still the matter of debate. Among laser applications, low-level laser therapy is recommended for its pain-reducing, woundhealing and anti-inflammatory effects. Hyaluronic acid is a non-sulfated glycosaminoglycan and a major component of the extracellular matrix. It is found in various body fluids, such as gingival crevicular fluid, saliva, serum and synovial fluid. Anti-inflammatory, anti-edematous and anti-bacterial activities of hyaluronic acid have been investigated in dentistry, specially in periodontology.

Detailed description

Each participant will be assigned in one of three groups. In each group there will be 15 participants. Different treatment protocols will be carried in each group as follows: group one (scaling and root planing), group two (scaling and root planing + LASER), group three (scaling and root planing + hyaluronic acid). Under local anesthesia we will perform scaling and root planing of the teeth in two sessions. The procedure be made with the use of ultrasonic (PiezoLED Scaler, KaVo, Biberach, DE) and hand instruments (Gracey, Hu Friedy, Chicago, IL, USA). In group one, only scaling and root planning (SRP) will be made. In group two, the use of a diode laser (Dentsply Sirona - SIROLaser Blue) will be added to the therapy. In group three, after the performance of SRP, a gel containing hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic acid gel) will be applied intrasulcular.

Interventions

  • Device SRP+LASER (Dentsply Sirona - SIROLaser Blue)
    adjunct irradiation with a diode laser (Dentsply Sirona - SIROLaser Blue) intrasulcularly to all sites with PD ≥ 4mm
  • Device SRP+HA
    adjunct hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic intrasulcularly to all sites with PD ≥ 4mm
  • Device SRP
    non-surgical periodontal therapy (SRP) with utrasonic device and curretes

Primary outcome measures

  • Probing pocket depth reduction [Time frame: 3 months, 6 months]
Secondary outcome measures (3)
  • Clinical attachment level gain [Time frame: 3 months, 6 months]
  • Bleeding on probing percentage reduction [Time frame: 3 months, 6 months]
  • Residual diseased site number [Time frame: 3 months, 6 months]

Eligibility criteria

Inclusion criteria

  • systemically healthy
  • nonsmokers
  • untreated periodontal disease (stage 3, grade B or C)
  • plaque index will not exceed 20%
  • at least 20 teeth in oral cavity

Exclusion criteria

  • systemic diseases with impact on periodontal health
  • medication with impact on periodontal health
  • smokers
  • pregnant and lactating women
  • patients treated with antibiotics in the last 12 months
  • patients who had undergone periodontal treatment in the last year

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Slovenia · 1 center
  • Univerity Medical Center Ljubljana — Ljubljana

Identifiers

NCT: NCT05907161 · HA AND LASERS IN PERIO TH

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗